Methyl Folate Plus
Methyl Folate Plus is a focused vitamin supplement containing only three active ingredients, all of which are clearly listed with 100% label transparency. This product provides Riboflavin (30mg), Niacin (125mg), and Folate (9770mcg DFE), with all three ingredients present at dosages that research suggests are clinically effective. The product achieved an N+ Score of 65, resulting in a 'D' grade, placing it in the average tier. Its strength lies in the adequate dosing of its limited, targeted ingredients, particularly for those looking for robust folate support. This supplement may be beneficial for individuals specifically seeking high-dose B vitamin support, especially folate, without additional ingredients.
About This Product
Methyl Folate Plus by Neurobiologix is a vitamins & minerals supplement containing 3 active ingredients. It has earned an N+ Score of 65/100 (Grade D).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Riboflavin, Niacin, Folate.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +3 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (3 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Riboflavin | 30.000 mg | Optimal |
| Niacin | 125.000 mg | High |
| Folate | 9770.000 mcg DFE | High |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.